Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Van Ewijk, CE"" wg kryterium: Autor


Wyświetlanie 1-9 z 9
Tytuł:
Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May-July 2022.
Autorzy:
van Ewijk CE; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. Electronic address: katja.van.ewijk@rivm.nl.
Smit C; Department of Infectious Diseases, Public Health Service of Amsterdam, The Netherlands.
Bavalia R; Department of Infectious Diseases, Public Health Service of Amsterdam, The Netherlands.
Ainslie K; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; School of Public Health, University of Hong Kong, Hong Kong Special Administrative Region, China.
Vollaard A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van Rijckevorsel G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Infectious Diseases, Public Health Service of Amsterdam, The Netherlands.
Hahné SJM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2023 Nov 13; Vol. 41 (47), pp. 6952-6959. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mpox (monkeypox)*
Sexual and Gender Minorities*
Male ; Humans ; Homosexuality, Male ; Netherlands/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł:
Letter to the editor: Bias in the vaccine effectiveness estimates of one-dose post-exposure prophylaxis against mpox.
Autorzy:
van Ewijk CE; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Hahné SJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Pokaż więcej
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Aug; Vol. 28 (34).
Typ publikacji:
Letter; Comment
MeSH Terms:
Mpox (monkeypox)*/prevention & control
Vaccine Efficacy*
Humans ; Post-Exposure Prophylaxis
Opinia redakcyjna
Tytuł:
Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine.
Autorzy:
van Ewijk CE; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
Miura F; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Centre for Marine Environmental Studies, Ehime University, Matsuyama, Japan.
van Rijckevorsel G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
de Vries HJ; Amsterdam UMC location University of Amsterdam, Department of Dermatology, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunology, Infectious Diseases, Amsterdam, the Netherlands.; Centre for Sexual Health, Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.
Welkers MR; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.; Amsterdam UMC location AMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands.
van den Berg OE; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Friesema IH; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
van den Berg PR; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Dalhuisen T; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Wallinga J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands.
Brandwagt D; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
van Cleef BA; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
Vennema H; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Voordouw B; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Koopmans M; Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands.
van der Eijk AA; Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands.
Swaan CM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Te Wierik MJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Leenstra T; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Op de Coul E; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Franz E; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Pokaż więcej
Corporate Authors:
Dutch Mpox Response Team; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands.; Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands.; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.; Centre for Marine Environmental Studies, Ehime University, Matsuyama, Japan.; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.; Amsterdam UMC location University of Amsterdam, Department of Dermatology, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunology, Infectious Diseases, Amsterdam, the Netherlands.; Centre for Sexual Health, Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.; Amsterdam UMC location AMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands.
Members of the Dutch Mpox Response Team
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Mar; Vol. 28 (12).
Typ publikacji:
Journal Article
MeSH Terms:
Smallpox Vaccine*
Mpox (monkeypox)*/diagnosis
Mpox (monkeypox)*/epidemiology
Mpox (monkeypox)*/prevention & control
Sexual and Gender Minorities*
Male ; Humans ; Female ; Public Health ; Netherlands/epidemiology ; Homosexuality, Male ; Travel ; Travel-Related Illness ; Disease Outbreaks/prevention & control ; Antigens, Viral ; Monkeypox virus
Czasopismo naukowe
Tytuł:
Response to Letter to the Editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies.
Autorzy:
van Ewijk CE; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Hahné SJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Pokaż więcej
Corporate Authors:
all co-authors of the original article; https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.45.2200217.
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Jan; Vol. 28 (4).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaign.
Autorzy:
van Ewijk CE; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, the Netherlands; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Gustav III:s Boulevard 40, 169 73, Solna, Stockholm, Sweden. Electronic address: katja.van.ewijk@rivm.nl.
Hazelhorst EI; Department of Infectious Disease prevention and Control, Public Health Facility Twente, Nijverheidstraat 30, 7511 JM Enschede, the Netherlands. Electronic address: .
Hahné SJM; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, the Netherlands. Electronic address: .
Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, the Netherlands. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2022 Nov 02; Vol. 40 (46), pp. 6664-6669. Date of Electronic Publication: 2022 Oct 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Aged ; COVID-19 Vaccines ; Vaccine Efficacy ; SARS-CoV-2 ; Immunization Programs ; Disease Outbreaks/prevention & control
Czasopismo naukowe
Tytuł:
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021.
Autorzy:
van Ewijk CE; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Kooijman MN; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Fanoy E; Department of Infectious Diseases, Public Health Service Amsterdam-Amstelland, Amsterdam, the Netherlands.
Raven SF; Department of Infectious Diseases, Public Health Service Utrecht region, Utrecht, The Netherlands.; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Middeldorp M; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Shah A; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
de Gier B; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
de Melker HE; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Hahné SJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Pokaż więcej
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2022 Nov; Vol. 27 (45).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/epidemiology
COVID-19*/prevention & control
Adult ; Humans ; Middle Aged ; Netherlands/epidemiology ; Case-Control Studies ; Vaccine Efficacy ; SARS-CoV-2 ; RNA, Messenger
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022.
Autorzy:
Miura F; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Center for Marine Environmental Studies (CMES), Ehime University, Ehime, Japan.
van Ewijk CE; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Backer JA; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Xiridou M; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Franz E; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Op de Coul E; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Brandwagt D; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
van Cleef B; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
van Rijckevorsel G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Department of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, the Netherlands.
Swaan C; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
van den Hof S; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Wallinga J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
Pokaż więcej
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2022 Jun; Vol. 27 (24).
Typ publikacji:
Journal Article
MeSH Terms:
Disease Outbreaks*
Mpox (monkeypox)*/diagnosis
Mpox (monkeypox)*/epidemiology
Humans ; Infectious Disease Incubation Period ; Monkeypox virus ; Netherlands/epidemiology
Czasopismo naukowe
Tytuł:
Epidemiologic and Genomic Analysis of SARS-CoV-2 Delta Variant Superspreading Event in Nightclub, the Netherlands, June 2021.
Autorzy:
Koopsen J
van Ewijk CE
Bavalia R
Cornelissen A
Bruisten SM
de Gee F
Han AX
de Jong M
de Jong MD
Jonges M
Khawaja N
Koene FMHPA
van der Lubben M
Mikulic I
Rebers SPH
Russell CA
Schinkel J
Schreijer AJM
den Uil JA
Welkers MRA
Leenstra T
Pokaż więcej
Corporate Authors:
ARGOS consortium
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2022 May; Vol. 28 (5), pp. 1012-1016. Date of Electronic Publication: 2022 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
SARS-CoV-2*/genetics
Genomics ; Humans ; Netherlands/epidemiology
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Unsuspected serotonin toxicity in the ICU.
Autorzy:
van Ewijk CE; Department of Intensive Care 7D16, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.
Jacobs GE; Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.; Centre for Human Drug Research, Leiden, The Netherlands.
Girbes ARJ; Department of Intensive Care 7D16, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Annals of intensive care [Ann Intensive Care] 2016 Dec; Vol. 6 (1), pp. 85. Date of Electronic Publication: 2016 Sep 02.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-9 z 9

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies